The short version of AEDG fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-12-09 and is reviewed periodically as new material appears.
Several names circulate for the same molecule, including epitalon, epithalone, epithalamin tetrapeptide, and the sequence code AEDG. A CAS registry number, 307297-39-8, is commonly cited for it, though catalogue entries should be checked against supplier documentation because mislabelled records occur. In its usual form the peptide carries free amino and carboxyl termini and is neither glycosylated nor lipidated. Researchers distinguish the defined tetrapeptide from epithalamin itself, a crude pineal preparation containing many peptides that is not chemically characterised.
Material supplied for laboratory use is normally a lyophilised white to off-white powder that dissolves readily in water and in isotonic saline. Lyophilised cakes are hygroscopic and should be equilibrated to room temperature before opening to limit condensation on the solid. Solutions are typically prepared at milligram-per-millilitre concentrations and divided into single-use aliquots, because repeated freeze–thaw cycles degrade short peptides. Aqueous solutions are far less stable than the dry powder, and identity is usually verified by mass spectrometry alongside purity estimation from reversed-phase high-performance liquid chromatography.
Epitalon is a synthetic linear tetrapeptide with the sequence alanine–glutamate–aspartate–glycine, abbreviated AEDG. Its molecular formula is C14H22N4O9 and the calculated mass is approximately 390.35 g/mol. The compound is made by solid-phase peptide synthesis rather than extracted from tissue, although early work described it as a short fragment of a peptide fraction obtained from bovine pineal extract. In the research literature the spelling epitalon and the variant epithalone both appear, while AEDG is the standard code used in peptide nomenclature.
Storage recommendations center on limiting moisture, heat, and light. The dry powder is generally kept at minus 20 degrees Celsius, and some suppliers recommend minus 80 degrees for long-term archival. Once dissolved, solutions are usually aliquoted and frozen to avoid repeated freeze-thaw cycles, which can promote aggregation or degradation. Aqueous stability depends on pH and concentration, and buffered saline is often preferred over plain water for biological work. Stability data specific to epitalon remain limited, so general peptide-handling practices are applied by analogy rather than from product-specific validation.
Epitalon is a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, abbreviated AEDG. Its molecular formula is C14H22N4O9 and its calculated monoisotopic mass is approximately 390.35 daltons. The compound does not occur naturally as a free peptide; it is produced by solid-phase peptide synthesis. Because it contains two acidic residues and no basic residues, the neutral form carries a net negative charge at physiological pH. This charge profile influences how the peptide behaves in solution and during chromatographic analysis.
Laboratory-grade epitalon is typically supplied as a lyophilized powder. Purity is commonly assessed with reverse-phase high-performance liquid chromatography, often paired with mass spectrometry to confirm molecular identity. Amino acid analysis and peptide mapping can provide additional confirmation of sequence. Certificates of analysis for research materials frequently report purity above 95 percent, although the methods behind such figures vary between suppliers. The absence of a pharmacopeial monograph means that no single standardized assay defines the compound, so reported results depend on the analytical protocol chosen.
| Property | Value | Notes |
|---|---|---|
| Amino acid sequence | Ala-Glu-Asp-Gly | Linear tetrapeptide, also written AEDG |
| Molecular mass | About 390.35 g/mol | Value calculated from the sequence |
| Appearance | White to off-white powder | Lyophilised material forms a loose cake |
| Solubility | Freely soluble in water | Also dissolves in isotonic saline |
| Storage | -20 °C, desiccated | Aliquot solutions to avoid freeze–thaw cycling |
The parent extract epithalamin was characterised as a low-molecular-weight fraction of pineal tissue rather than a single defined chemical entity. Researchers fractionated it and tested successive fragments for activity, a screening approach typical of peptide discovery work in that era. Epitalon emerged from that process as one of the shorter sequences of interest. Because the original extract was never fully resolved into individual components, claims about which constituent drives a given effect rest on inference. This distinction matters when reading older reports that attribute extract observations to the tetrapeptide itself.
Epitalon is a synthetic tetrapeptide with the residue sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its monoisotopic mass is approximately 390.35 daltons, and it is usually supplied as a lyophilised trifluoroacetate or acetate salt. The compound was derived from a pineal gland extract called epithalamin, a heterogeneous preparation investigated in the former Soviet Union. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology described the tetrapeptide as a constituent fragment of that extract. Commercial material is offered as a laboratory reagent rather than as a finished pharmaceutical product.
Epitalon is a synthetic tetrapeptide whose four residues are alanine, glutamate, aspartate and glycine, commonly abbreviated AEDG. Its molecular formula is C14H22N4O9 and its monoisotopic mass is near 390.35 daltons. The peptide carries two acidic side chains, so it is neutral to negatively charged in most aqueous buffers. Published reference summaries usually list it under both spellings, epitalon and epithalon, and treat the two names as the same material.
The compound is generally described as a synthetic analogue of a fragment isolated from a pineal gland extract. Researchers associated with the Saint Petersburg Institute of Bioregulation and Gerontology introduced it during the 1980s and 1990s while studying short peptides from animal tissue. The original extract, called epithalamin, is a heterogeneous mixture, whereas epitalon is a single defined sequence. That distinction matters because findings reported for the extract are not automatically findings about the pure tetrapeptide, and claims about broader biological effects remain a separate question from the chemical identity described here.
The peptide emerged from research carried out in Saint Petersburg from the late 1980s onward, where investigators searched for shorter active fragments of a pineal preparation known as epithalamin. The name epitalon was chosen to reflect that parent extract. Early reports described effects on neuroendocrine markers and on the lifespan of laboratory animals. Much of that work appeared in Russian-language journals, with English translations following later, which affects how readily the original protocols can be assessed by outside groups.
Published studies on epitalon are dominated by a small number of research groups, and independent replication in other laboratories remains limited. Proposed mechanisms include activation of telomerase and modulation of melatonin rhythms, but the evidence for either rests mainly on cell cultures and animal models. Whether the peptide produces comparable effects in humans is an open question, and the absence of large controlled trials means the literature is best read as exploratory rather than settled.
Epitalon is a synthetic four-amino-acid peptide with the sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its molecular formula is C14H22N4O9, and its calculated molar mass is approximately 390.35 grams per mole. The compound is a short fragment related to a peptide fraction isolated from bovine pineal gland extracts, and it is normally supplied as a lyophilised powder intended for laboratory research. It is not a registered pharmaceutical product in most countries.
For services to Music. David Wilkinson Cawthra, lately Director, Infrastructure Services Privatisation, British Railways Board. For services to the Railway Industry. Honor Mary Ruth Chapman, Partner, Jones Lang Wootton. For services to the Property Industry. William Herman MacKillop Clark, lately Head, Operational Re-organisation Division, Crown Prosecution Service. Owen J. D. Clarke, Controller, Scotland, Board of Inland Revenue. Stella Rosemary Clarke, . For services to the Community in Bristol. Betty St. Clair, The Honourable Mrs. Clay. For services to Guiding. John Brian Clayton, Chairman, Bridon plc. For services to Industry and to Export. Donald Thomas Younger Curry, Chairman, Meat and Livestock Commission. For services to Agriculture. William Wentworth Daniel. For services for Industrial Relations. Edward Charles Dart, Research and Development Director, Zeneca Seeds. For services to Industry and to Science. Edmund Leopold de Rothschild, . For charitable services. Nicholas Dampier Deakin. For services to the Commission on the Future of the Voluntary Sector. Anthony Albert Denton, Chairman, Noble Denton International Ltd. For services to Engineering. Roger Joseph Dickens, , Deputy U.K Senior Partner, KPMG. For services to Industry in the West Midlands. Judith Donovan, Chair, Bradford & District Training and Enterprise Council. For services to Training. Olga Lindholm Driver, Senior Partner, Aiking Driver Partnership. For services to ACAS and to Industrial Relations. Francis Cuthbert Duffy. For services to Architecture. Professor John Edwin Enderby, , lately H. O.
=== Infectious hypotheses === One hypothesis suggests that prenatal viral infection may contribute to the development of autism. Prenatal exposure to rubella or cytomegalovirus activates the mother's immune response and may greatly increase the risk for autism in mice. Congenital rubella syndrome is the most convincing environmental cause of autism. Infection-associated immunological events in early pregnancy may affect neural development more than infections in late pregnancy, not only for autism, but also for psychiatric disorders of presumed neurodevelopmental origin, notably schizophrenia. A 2021 meta-analysis of 36 studies suggested a relationship between mothers recalling an infection during pregnancy and having children with autism.
=== High population densities === Since sea ice pockets are confined and highly-concentrated ecosystems, they are able to house several orders of magnitude greater population densities of bacteria and protists than are found in the open ocean (up to thousands of individuals per liter for protists). This high abundance of organisms can pose challenges, as different bacteria and protists will compete for resources. A high density of microorganisms can result in the accumulation of metabolic byproducts, such as oxygen, dissolved organic matter, ammonia, and dimethylsulfoniopropionate (DMSP). Some organisms can gain a selective advantage within brine pockets as the high population density can result in increased rates of horizontal gene transfer because organisms are in close proximity. Horizontal gene transfer can allow certain organisms to obtain genes from bacteria that may be advantageous in a light-limited, extremely cold environment.
The mdx mouse has been at the forefront of CRISPR-Cas9 gene editing research for Duchenne muscular dystrophy. In 2014, the first successful correction of the dystrophin mutation using CRISPR-Cas9 was demonstrated directly in mdx mice, marking a historic milestone in gene editing therapy. In 2018, researchers used AAV-delivered CRISPR-Cas9 to restore dystrophin expression in mdx mice following a single systemic injection, demonstrating the remarkable potential of this approach. These results in mdx mice directly led to the first CRISPR-based clinical trials for DMD in human patients, representing a direct translation from mouse model to human medicine.
==== Endorsement negotiations ==== On 12 February, Leonidas Iza categorically rejected any negotiations with Noboa's party, the ADN. He announced that several meetings would take place within CONAIE (Confederation of Indigenous Nationalities of Ecuador) and its political arm, the Pachakutik Party, to determine their stance on a potential alliance with the Citizens' Revolution for the second presidential round and beyond. On 13 February, Diego Borja, the vice-presidential candidate for Citizens Revolution, expressed a desire to initiate a joint program with Pachakutik. The primary objective is to establish a National Constituent Assembly that includes the proposal to redefine Ecuador as a Plurinational State, akin to Bolivia. On 19 February, Leonidas Iza announced the convocation of an Expanded Grand Council for 7 March 2025, where indigenous peoples would make the final decision on currently debated proposals for a programmatic political alliance with the Citizens' Revolution Movement. On 14 February the Social Christian Party announced that they would support Daniel Noboa in the second round, saying "We have never supported or voted for Rafael Correa in any election". On 12 March, CONAIE's branch in the Amazon region, CONFENIAE, endorsed Noboa, triggering a dispute within the organization and in Pachakutik. On 30 March, Pachakutik endorsed Luisa González after she had agreed to 25 demands listed by the party.
Sources: en.wikipedia.org
== Hazards == Americium-241 has the same general hazards as other americium isotopes: it is both extremely toxic and radioactive. Though α-particles can be stopped by a sheet of paper, there are serious health concerns for ingestion of α-emitters. Americium and its isotopes are also very chemically toxic as well, in the form of heavy-metal toxicity. As little as 0.03 microcuries (1.1 kBq) is the maximum permissible body burden for 241Am. Americium-241 is an α-emitter with a weak γ-ray byproduct. Safely handling americium-241 requires knowing and following proper safety precautions, as without them it would be extremely dangerous. Its specific gamma dose constant is 3.14×10−1 mR/hr/mCi or 8.48×10−5 mSv/hr/MBq at 1 metre (3 ft 3 in). If consumed, americium-241 is excreted within a few days and only 0.05% is absorbed in the blood. From there, roughly 45% of it goes to the liver and 45% to the bones, and the remaining 10% is excreted. The uptake to the liver depends on the individual and increases with age. In the bones, americium is first deposited over cortical and trabecular surfaces and slowly redistributes over the bone with time. The biological half-life of 241Am is 50 years in the bones and 20 years in the liver, whereas in the gonads (testicles and ovaries) it remains permanently; in all these organs, americium promotes formation of cancer cells as a result of its radioactivity.
== Medical use == Lixisenatide is used as adjunct to diet and exercise to treat type 2 diabetes. In the European Union, its use is limited to complementing insulin therapy. As of 2017 it is unclear if they affect a person's risk of death. It is provided in an autoinjector containing fourteen doses and is injected subcutaneously. Lixisenatide should not be used for people who have problems with stomach emptying. Lixisenatide delays emptying of the stomach, which may change how quickly other drugs that are taken by mouth take effect.
In the United States, dog foods labelled as "complete and balanced" must meet standards established by the Association of American Feed Control Officials (AAFCO), either by meeting a nutrient profile or by passing a feeding trial. The Dog Food Nutrient Profiles were last updated in 2016 by the AAFCO's Canine Nutrition Expert Subcommittee. Critics argue that due to the limitations of the trial and the gaps in knowledge within animal nutrition science, the term "complete and balanced" is inaccurate and even deceptive. An AAFCO panel expert has stated that "although the AAFCO profiles are better than nothing, they provide false securities." Certain manufacturers label their products with terms such as "premium", "ultra premium", "natural", and "holistic". Such terms currently have no legal definitions and are not regulated. There are also varieties of dog food labeled as "human-grade food." Although no official definition of this term exists, the assumption is that other brands use foods that would not pass US Food and Drug Administration inspection according to the Pure Food and Drug Act or the Meat Inspection Act. The ingredients on the label must be listed in descending order by weight before cooking. This means before all of the moisture is removed from the meat, fruits, vegetables and other ingredients used.
=== Pest control === Diatomite is of value as an insecticide because of its abrasive and physico-sorptive properties. The fine powder adsorbs lipids from the waxy outer layer of the exoskeletons of many species of insects. This layer acts as a barrier that resists the loss of water vapour from the insect's body. Damaging the layer increases the evaporation of water from their bodies, so that they dehydrate, often fatally. This also works against gastropods and is commonly employed in gardening to defeat slugs. However, since slugs inhabit humid environments, efficacy is low. Diatomaceous earth is sometimes mixed with an attractant or other additives to increase its effectiveness. The shape of diatoms has not been proven to affect their functionality as regarding adsorption of lipids. However, certain applications, such as that for slugs and snails, work best when a particularly shaped diatom is used, suggesting that lipid adsorption is not the only factor involved. For example, in the case of slugs and snails, large, spiny diatoms work best to lacerate the epithelium of the mollusk. Diatom shells will work to some degree on the vast majority of animals that undergo ecdysis in shedding cuticle, such as arthropods or nematodes. It also may have other effects on lophotrochozoans, such as mollusks or annelids. Medical-grade diatomite has been studied for its efficacy as a deworming agent in cattle; in both studies cited the groups being treated with diatomaceous earth did not fare any better than control groups.
Sources: en.wikipedia.org
It is a synthetic tetrapeptide. Its sequence was derived from research on peptide fractions of bovine pineal extract, and the intact AEDG sequence has not been demonstrated as an abundant free peptide in human tissue.
AEDG is the one-letter code for the four amino acids alanine, glutamate, aspartate and glycine in that order. The same molecule is written in three-letter form as Ala-Glu-Asp-Gly.
Identity is normally confirmed by mass spectrometry against the calculated mass of roughly 390.35 g/mol. Purity is then estimated by reversed-phase high-performance liquid chromatography with ultraviolet detection.
Epitalon is a synthetic tetrapeptide built from four amino acids: alanine, glutamate, aspartate, and glycine. It is not extracted from a natural source but made in the laboratory by chemical synthesis. Its short length makes it relatively straightforward to produce at high purity.